The following is a summary of “Changes in use of migraine medications, healthcare resource utilization, and associated direct costs over 12 Months following initiation of Erenumab: A US retrospective ...
Erenumab effectively induces Medication Overuse Headache remission in chronic migraine patients. Monthly 140 mg injections ...
Monthly use of erenumab injections (140 mg) is safe and effective in achieving medication overuse headache (MOH) remission in ...
Subcutaneous ocrelizumab and hyaluronidase (Ocrevus Zunovo) was approved for relapsing and progressive multiple sclerosis, ...
In this study, monthly, 140 mg erenumab injections safely and effectively achieved medication overuse headaches remission in patients ...
In this study, monthly, 140 mg erenumab injections safely and effectively achieved medication overuse headaches remission in patients with nonopioid chronic migraine and medication overuse headaches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback